Open original FDA record ↗Recall record
- FDA identifier
- Z-0930-2021
- Company in FDA record
- Braxton Medical Corporation
- FDA record creation date
- Jan 27, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Recalled products do not have FDA approval for sale in the United States.
Source facts
- Action
- On 9/4/2020 the firm sent a letter to its consignees with the following instructions. It has been brought to our attention that these products have not been approved by the FDA for sale in the United States. Please examine your inventory immediately and discontinue distribution of these products. Please identify and notify your customers that were shipped these products. Any remaining stock of these products should be quarantined and returned for a credit. Promptly complete the attached recall stock response form even if you have no product to return. Completed response forms can be submitted by any of the following methods: Fax to: (813)975-0611 or Email to: documents@braxmed.com or Mail to: Braxton Medical Attn: Felicia Stivers, 15494 N. Nebraska Ave., Lutz FL 33549.
- Initiated
- 2020-09-04
- Root cause
- No Marketing Application
- Distribution
- US Nationwide distribution including in the states of AL, CA, CT, FL, GA, IL, KS, LA, MI, MN, NC, NJ, NY, PA, SD, TX, WA.
- Recall number
- Z-0930-2021
- Recall status
- Open, Classified
- CDRH record ID
- 183721
- FDA record created
- 2021-01-27
- Recall event number
- 86443